Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

HLA-A*02:01 (Monomer) protein (Biotin,MAGE-A2)

Origine: Humain Hôte: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
N° du produit ABIN7504361
  • Antigène
    HLA-A*02:01
    Type de proteíne
    Recombinant
    Attributs du protein
    Monomer
    Origine
    • 70
    • 4
    Humain
    Source
    • 65
    • 4
    • 1
    HEK-293 Cells
    Purification/Conjugué
    Biotin,MAGE-A2
    Fonction
    Biotinylated Human HLA-A*02:01 & B2M & MAGE-A2 (KMVELVHFL) Monomer Protein
    Séquence
    Gly25-Thr305 (HLA-A*02:01), Ile21-Met119 (B2M) and KMVELVHFL peptide
    Specificité
    Uni-Prot: A0A140T913 (HLA-A*02:01), P61769 (B2M), KMVELVHFL
    Attributs du produit
    Recombinant Biotinylated Human HLA-A*02:01 & B2M & MAGE-A2 (KMVELVHFL) Monomer Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and KMVELVHFL peptide.
    Pureté
    > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
    Stérilité
    0.22 μm filtered
    niveau d'endotoxine
    Less than 1EU per μg by the LAL method.
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.
    Buffer
    Lyophilized from 0.22 μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    -20 to -80°C for 12 months as supplied from date of receipt., -80°C for 3-6 months after reconstitution., 2-8°C for 2-7 days after reconstitution., Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
    Date de péremption
    12 months
  • Antigène
    HLA-A*02:01
    Sujet
    Melanoma antigen gene (MAGE)-A2 (MAGEA2) is a member of the MAGE-A family proteins widely studied for cancer vaccine development and identification of tumor markers. MAGEA2 plays an oncogenic role in glioma progression, and they provide insight into MAGEA2 application as a novel predictor of clinical outcomes and a potential glioma biomarker.
    Poids moléculaire
    50.50 kDa. Due to glycosylation, the protein migrates to 52-62 kDa based on Tris-Bis PAGE result.
    UniProt
    A0A140T913
Vous êtes ici: